Avivagen (CVE:VIV) Trading Down 4.2%
Avivagen Inc (CVE:VIV) was down 4.2% during trading on Monday . The stock traded as low as C$0.45 and last traded at C$0.46, approximately 16,210 shares were traded during trading. A decline of 78% from the average daily volume of 74,015 shares. The stock had previously closed at C$0.48.
The company has a fifty day moving average price of C$0.55 and a 200 day moving average price of C$0.59. The company has a market cap of $20.83 million and a PE ratio of -3.31. The company has a debt-to-equity ratio of 2,402.32, a current ratio of 1.50 and a quick ratio of 1.13.
Avivagen Company Profile (CVE:VIV)
Avivagen Inc develops and commercializes various products to replace antibiotics in livestock feeds to optimize the health and growth of the animals by supporting the animal's own health defenses. The company offers products based on its OxC-Beta technology, such as OxC-beta Livestock, a premix for livestock feeds; and Vivamune Health Chews supplements for companion animals.
Recommended Story: Neutral Rating
Receive News & Ratings for Avivagen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avivagen and related companies with MarketBeat.com's FREE daily email newsletter.